Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trialJohn Chia, Han Chong Toh, Eva Segelov et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 34
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyJianqiu Wu, Jifeng Feng, Mingzhi Zhang et al.|BMC Cancer|2016Cited by 32
Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancerDe‐Shen Wang, Yuhong Li, Zhi‐Qiang Wang et al.|Cancer Medicine|2019Cited by 28